Oscar Health’s (OSCR) “Sell” Rating Reaffirmed at UBS Group

Oscar Health (NYSE:OSCR)‘s stock had its “sell” rating reissued by research analysts at UBS Group in a note issued to investors on Tuesday, Marketbeat.com reports. They presently have a $11.00 target price on the stock, down from their previous target price of $15.00. UBS Group’s price objective points to a potential downside of 27.48% from the company’s previous close.

Several other equities analysts have also recently weighed in on the stock. Wells Fargo & Company cut shares of Oscar Health from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $16.00 to $10.00 in a research note on Friday. Raymond James Financial lowered Oscar Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 24th. Wall Street Zen downgraded shares of Oscar Health from a “buy” rating to a “hold” rating in a research report on Sunday, June 8th. Piper Sandler lowered shares of Oscar Health from an “overweight” rating to a “neutral” rating and set a $14.00 price target on the stock. in a report on Monday. Finally, Barclays assumed coverage on Oscar Health in a report on Wednesday, July 2nd. They issued an “underweight” rating and a $17.00 price target for the company. Five analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Reduce” and an average price target of $12.92.

Oscar Health Stock Performance

NYSE:OSCR opened at $15.17 on Tuesday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.79. The firm’s fifty day simple moving average is $16.35 and its 200 day simple moving average is $14.90. The stock has a market cap of $3.86 billion, a P/E ratio of 54.17 and a beta of 1.90.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same period last year, the business posted $0.62 EPS. The company’s revenue was up 42.2% compared to the same quarter last year. As a group, research analysts predict that Oscar Health will post 0.69 EPS for the current year.

Insider Activity

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director directly owned 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

Several hedge funds have recently made changes to their positions in the company. Jones Financial Companies Lllp increased its stake in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in shares of Oscar Health in the first quarter worth about $30,000. Larson Financial Group LLC grew its position in Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after acquiring an additional 2,512 shares in the last quarter. CWM LLC boosted its position in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock valued at $45,000 after purchasing an additional 2,854 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.